Product Risk Warning:

Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in below products, investor should refer to the Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:

Important Information about ChinaAMC MSCI China A 50 Connect ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the MSCI China A 50 Connect Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund’s investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in a single geographical region (Mainland China). The Fund may be more volatile than a broadly-based fund.
• The Fund is subject to risks associated with the Stock Connect, such as change of relevant rules and regulations, quota limitations, suspension of the Stock Connect programme.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. Non-RMB based investors in units are exposed to foreign exchange risk.
• As the SSE and the SZSE may be open when units in the Fund are not priced, the value of the securities in Fund’s portfolio may change on days when investors will not be able to purchase or sell the Fund’s units. Differences in trading hours between the SSE, the SZSE and the SEHK, and A-Shares’ trading bands may increase the level of premium/discount of the unit price to its NAV.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK, of which the trading price is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the RMB only. Unitholder without RMB account may have to bear the fees and charges associated with currency conversion.
• The Fund may at its discretion pay distribution out of capital or effectively out of capital. Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor’s original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.

Important Information about ChinaAMC Hang Seng Hong Kong Biotech Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng Hong Kong-Listed Biotech Index (the "Index").
• The Fund is passively managed. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in biotech companies and in a particular geographical region (i.e. Hong Kong and mainland China). The Fund may be more volatile than a broadly-based fund.
• The Fund is exposed to risks associated with characters of biotech companies, such as pre-revenue, incurrence of net current liabilities, lower liquidity, higher volatility, dependency on intellectual property rights or patents, technological changes, increased regulations and intense competition.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• The Fund is subject to tracking error risk.
• If any suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter. The market price of units traded in each counter may deviate significantly.
• Unitholders will receive distributions in the HKD only. Non HKD based unitholder may have to bear bank or financial institution fees and charges associated with currency conversion.
• The Fund's base currency is HKD but has units traded in USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC Hang Seng TECH Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Hang Seng TECH Index (the "Index").
• The Fund is passively managed and the Manager will not have the discretion to adapt to market changes. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• The Fund's investment in equity securities is subject to general market risks, whose value may fluctuate due to various factors.
• The Index is a new index. The Fund may be riskier than those tracking more established indices with longer operating history.
• The Fund is subject to concentration risks in companies with technology theme and in a single geographical region (i.e., Greater China). The Fund may be more volatile than a broadly-based fund.
• Companies in the technology sector are characterised by relatively higher volatility in price performance when compared to other sectors.
• The Fund may be exposed to risks associated with different technology sectors and themes. A downturn in the business for companies in these sectors or themes may have adverse effects on the Fund.
• The Fund is subject to tracking error risk, which may result from the investment strategy used, and fees and expenses.
• If there is a suspension of the inter-counter transfer of units and/or any limitation on the level of services by brokers and CCASS participants, Unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing. The market price of units traded in each counter may deviate significantly.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC CSI 300 Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the CSI 300 Index (the "Index"). The Fund invests in the PRC's securities market through the Manager's RQFII status and the Stock Connect.
• The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and may likely be more volatile than a broad-based fund.
• The Fund is subject to risks relating to the RQFII regime, such as change of rules and regulations, default in execution or settlement of transaction by a PRC broker or the PRC Custodian and repatriation restrictions.
• The Fund is subject to risks associated with the Stock Connect, such as change of relevant rules and regulations, quota limitations, suspension of the Stock Connect programme.
• Investing in the PRC, involve greater political, tax, economic, foreign exchange, liquidity, legal and regulatory risks.
• If there is a suspension of the inter-counter transfer of units between counters, the unitholders will only be able to trade their units in the relevant counter on the SEHK. The market price on the SEHK of units traded in different counters may deviate significantly due to different factors, as such investors may pay more or receive less when buying units traded in HKD on the SEHK than in respect of units traded in RMB and vice versa.
• As the SSE and the SZSE may be open when units in the Fund are not priced, the value of the securities in Fund's portfolio may change on days when investors will not be able to purchase or sell the Fund's units. Differences in trading hours between the SSE and the SZSE, and the SEHK and A-Shares' trading bands may increase the level of premium/discount of the unit price to its NAV.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. A non-RMB based investors in units are exposed to foreign exchange risk.
• The Fund is subject to securities lending transactions risks, including the risk that the borrower may fail to return the securities in a timely manner.
• Payment of dividends out of capital or effectively out of capital amounts to a return or withdrawal of part of an investor's original investment or from any capital gains attributable to that original investment. Any distributions may result in an immediate reduction in the NAV per Unit of the Fund.
• The Fund is subject to tracking error risk.
• The Fund is not "actively managed" and therefore, when there is a decline in the Index, the Fund will also decrease in value.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC NASDAQ 100 ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ-100 Index. The Fund concentrates its investment in securities listed on the NASDAQ Stock Market and is subject to concentration risk as a result of tracking the performance of markets in a single country (the US) and securities listed on a single exchange (the NASDAQ Stock Market). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in the US. The value of securities in the Fund's portfolio may change on days when investors will not be able to purchase or sell units of the Fund as the NASDAQ Stock Market will be open when units of the Fund are not priced.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.
• The Fund's Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
• If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
• The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC Asia High Dividend ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ Asia ex Japan Dividend Achievers^TMIndex.
• The Fund primarily invests in high dividend yield securities in Asia. Such securities are subject to risks that the dividend could be reduced or abolished, or risks that the value of the securities could decline or have lower-than average potential for price appreciation.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Japan Hedged to USD ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Japan 100% Hedged to USD Index.
• The Fund concentrates its investment in Japanese securities and is subject to concentration risk as a result of tracking the performance of a single country (Japan). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Japan.
• The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund's returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Europe Quality Hedged to USD ETF

• The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI Europe Quality 100% Hedged to USD Index.
• The Fund concentrates its investment in European securities and is subject to concentration risk as a result of tracking the performance of a single geographical region (Europe). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Europe.
• The Fund invests in currency forward contracts for hedging purposes. While this approach is designed to minimise the impact of currency fluctuations on the Fund's returns, there are associated risks involved including costs of hedging, derivative and OTC transactions risks.
• The value of securities in the Fund's portfolio may change on days when investors will not be able to purchase or sell units of the Fund as European stock exchanges will be open when units of the Fund are not priced.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, cost of hedging and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC Hong Kong Banks ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the NASDAQ Hong Kong Banks^TMIndex. The Fund primarily invests in securities that are listed on The Stock Exchange of Hong Kong Limited and classified as Banks by the Industry Classification Benchmark (ICB).
• The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (Hong Kong) and sector (banking). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Hong Kong and the banking sector. Stock prices of financial service companies are also more sensitive to the movement of interest rates.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC MSCI Asia Pacific Real Estate ETF

• The Fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the MSCI AC Asia Pacific Real Estate Index.
• The Fund primarily invests in securities in the real estate sector in the Asia Pacific region, including real estate investment trusts (REITs). The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (Asia) and industry (real estate sector). It is likely to be more volatile than a broad-based fund as it is more susceptible to fluctuations in value resulting from adverse conditions in Asia and the real estate sector. There are risks associated with the real estate sector and REITs in particular.
• Investing in emerging markets involves a greater risk of loss than investing in more developed markets due to, among other factors, greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses and the representative sampling strategy that may be adopted by the Manager.

Important Information about ChinaAMC Asia USD Investment Grade Bond ETF

• The fund aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Bloomberg Asia USD Investment Grade Bond Index. The Fund primarily invests in fixed rate USD-denominated government-related and corporate investment grade bonds of the Asia ex-Japan region. Such investments involve special risks including interest rate risk, over-the-counter market risk, issuer risk, sovereign debt risk and illiquidity of bonds close to maturity risk.
• Investing in emerging markets involves a greater risk of loss than investing in more developed markets due to, among other factors, greater political, tax, economic, foreign exchange, liquidity and regulatory risks.
• The units of the Fund may trade at a substantial premium or discount to their NAV.
• The Fund is subject to tracking error risks due to factors such as fees and expenses, the representative sampling strategy adopted by the Manager and the liquidity of the underlying bonds.
• The Fund's Base Currency is in HKD but has units traded in USD (in addition to HKD). Investors may be subject to additional costs or losses associated with foreign currency fluctuations between the Base Currency and the USD trading currency when trading units in the secondary market.
• If there is a suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services provided by brokers and CCASS participants, unitholders will only be able to trade their units in one counter, which may inhibit or delay an investor dealing.
• The market price of units traded in each counter may deviate significantly due to different factors such as market liquidity, market supply and demand in each counter and the exchange rate fluctuations between HKD and USD.

Important Information about ChinaAMC Bloomberg China Treasury + Policy Bank Bond Index ETF

• The Fund aims to provide investment result that, before fees and expenses, closely corresponds to the performance of the Bloomberg China Treasury + Policy Bank Index (the "Index").
• The Fund is subject to concentration risk as a result of tracking the performance of a single geographical region (the PRC) and investing in bonds of a few issuers. The NAV of the Fund is likely to be more volatile than a broad-based fund.
• Investments in the PRC may involve increased risks compared to more developed markets, such as liquidity risks, currency risks/control, political and economic uncertainties, legal and taxation risks, settlement risks and custody risk.
• The Fund is subject to risks associated with Bond Connect and Foreign Access Regime, such as change of relevant rules and regulations, regulatory risks, volatility risk, liquidity risk, settlement and counterparty risk. The trading on the PRC interbank bond market or trading through Bond Connect may be suspended.
• The Fund is subject to risk associated with debt securities, such as credit / counterparty risk, interest rate risk, volatility and liquidity risk, downgrade risk, sovereign debt risk, valuation risk, credit rating risk and credit agency risk.
• The Fund is subject to risks relating to settlement procedures and default of counterparties on the PRC inter-bank bond market.
• The Fund is denominated in RMB. RMB is currently not freely convertible and is subject to exchange controls and restrictions. The Fund has units traded in HKD and USD. Investors may be subject to additional costs or losses associated with foreign currency fluctuations.
• The Fund may be subject to tracking error risk.
• If any suspension of the inter-counter transfer of units between the counters and/or any limitation on the level of services by brokers and CCASS participants occurs, unitholders will only be able to trade their units in one counter only. The market price of units traded in each counter may deviate significantly.
• The Fund is passively managed and the Manager will not have the discretion to adapt to market changes. Falls in the Index are expected to result in corresponding falls in the value of the Fund.
• Generally, retail investors can only buy or sell units of the Fund on the SEHK. The trading price of the units on the SEHK is driven by market factors such as the demand and supply of the units. Therefore, the units may trade at a substantial premium or discount to the Fund's NAV.

Important Information about ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product / ChinaAMC Nasdaq-100 Index Daily (-1x) Inverse Product / ChinaAMC Nasdaq-100 Index Daily (-2x) Inverse Product

• ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product ／ ChinaAMC Nasdaq-100 Index Daily (-1x) Inverse Product／ChinaAMC Nasdaq-100 Index Daily (-2x) Inverse Product (collectively, "Products") are futures-based leveraged/inverse products and are not suitable for all investors. The Products only target sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged/inverse results and the associated risks and constantly monitor the performance of their holdings on a daily basis.
• The Products invest directly in E-mini NASDAQ 100 Futures ("Nasdaq-100 Futures") which are traded on the Chicago Mercantile Exchange (the "CME"). The Products aim to provide daily investment results, before fees and expenses, which closely correspond to leveraged (2x) / inverse (-1x) / inverse (-2x) of the daily performance of the Nadsaq-100 Index (the "Nasdaq-100 Index").
• The Products do not seek to achieve their stated investment objectives over a period of time greater than one day.
• The Products are not intended for holding longer than one day as the performance of the Products over a longer period may deviate from and be uncorrelated to the leveraged/inverse performance of the Nasdaq-100 Index over the period (e.g. the loss may be more than 2 times the decrease in the Index/-1 time the increase in the Index /-2 times the increase in the Index). The Products are designed to be used for short term trading or hedging purposes, and are not intended for long term investment.
• Investing in the leveraged product is subject to the general market risk of equity investment, its value will be fluctuated because of multiple factors, and both gains and losses will be magnified. Investing in the inverse products is different from taking a short position. Because of rebalancing, the return profile of an inverse product is not the same as that of a short position. Risk investment outcomes of the inverse products are the opposite of conventional investment funds. If the value of the Index increases for extended periods, the inverse product will likely lose most or all of their values.
• The Products involve futures contracts risk, leveraged/inverse performance risk, risk of rebalancing activities, volatility risk, liquidity risk, intraday investment risk, portfolio turnover risk, concentration risk, US markets risk, Nasdaq-100 constituents risk, passive investment risk, reliance on the investment adviser risk, difference in price limit risk, trading time differences risk, trading risk, reliance on market maker risk, tracking error and correlation risk, termination risk, other currency distributions risk and currency risk.
• The Products are traded on SEHK, and there are trading time differences between SEHK, CME (where the Futures are traded) and the NASDAQ (where constituents of the Index are traded). The premium／discount of the unit prices of the Products to their NAVs may increase, and there may be imperfect correlation between the value of the index constituents and the Nasdaq-100 Futures, which may adversely affect the Products from tracking the leveraged (2x)／inverse (-1x)／inverse (-2x) daily performance of the Nasdaq-100 Index.

Important Information about ChinaAMC CSI 300 Index Daily (2x) Leveraged Product/ChinaAMC CSI 300 Index Daily (-1x) Inverse Product (The product is a synthetic product)

• ChinaAMC CSI 300 Index Daily (2x) Leveraged Product/ChinaAMC CSI 300 Index Daily (-1x) Inverse Product (collectively, "Products") are swaps-based leveraged/inverse products and are not suitable for all investors. The Products only target sophisticated trading-oriented investors who understand the potential consequences of seeking daily leveraged / inverse results and the associated risks and constantly monitor the performance of their holdings on a daily basis.
• The Products seeks to obtain the required exposure through swaps with different swap counterparties. The Products aim to provide daily investment results, before fees and expenses, which closely correspond to the leveraged (2x) / inverse (-1x) daily performance of the CSI 300 Index (the "Index").
• The Products do not seek to achieve their stated investment objectives over a period of time greater than one day.
• The Products are not intended for holding longer than one day as the performance of the Products over a longer period may deviate from and be uncorrelated to the leveraged/inverse performance of the Index over the period (e.g. the loss may be more than 2 times the decrease in the Index/-1 time the increase in the Index). The Products are designed to be used for short term trading or hedging purposes, and are not intended for long term investment.
• Investing in the leveraged product is subject to the general market risk of equity investment, its value will be fluctuated because of multiple factors, and both gains and losses will be magnified. Investing in the inverse products is different from taking a short position. Because of daily rebalancing, the return profile of an inverse product is not the same as that of a short position. Risk investment outcomes of the inverse products are the opposite of conventional investment funds. If the value of the Index increases for extended periods, the inverse products will likely lose most or all of their values.
• The Products also involve synthetic replication and counterparty risk, settlement risk, default risk, market risk, price movements risk, intraday counterparty risk, risk of increase in swap fees and early termination of swaps, derivative instrument investment risk, leveraged/inverse performance risk, risk of rebalancing activities, liquidity risk, intraday investment risk, currency risk, concentration risk, PRC market risk, risk of investment in debt securities and other funds, PRC tax risk, passive investment risk, trading risk, reliance on market maker risk, tracking error and correlation risk, volatility risk and termination risk.
• Swap counterparties of the Products may have daily capacity limits, when the limits are reached, the Products' ability to adjust the size of swaps for sufficient exposure to achieve their investment objectives may be adversely affected.